|The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials|
JP Higgins, DG Altman, PC Gotzsche, P Juni, D Moher, AD Oxman, ...
BMJ 343, d5928, 2011
|ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions|
JAC Sterne, MA Hernán, BC Reeves, J Savović, ND Berkman, ...
bmj 355, 2016
|Food, nutrition, physical activity, and the prevention of cancer: a global perspective|
World Cancer Research Fund, American Institute for Cancer Research
Amer Inst for Cancer Research, 2007
|Influence of reported study design characteristics on intervention effect estimates from randomized, controlled trials|
J Savović, HE Jones, DG Altman, RJ Harris, P Jüni, J Pildal, B Als-Nielsen, ...
Annals of internal medicine 157 (6), 429-438, 2012
|A revised tool for assessing risk of bias in randomized trials|
ES Higgins JPT, Sterne JAC, Savović J, Page MJ, Hróbjartsson A, Boutron I ...
Cochrane Methods. Cochrane Database of Systematic Reviews 2016 (10 (Suppl 1 …, 2016
|ROBIS: a new tool to assess risk of bias in systematic reviews was developed|
P Whiting, J Savović, JPT Higgins, DM Caldwell, BC Reeves, B Shea, ...
Journal of clinical epidemiology 69, 225-234, 2016
|Methods for causality assessment of adverse drug reactions|
TB Agbabiaka, J Savović, E Ernst
Drug safety 31 (1), 21-37, 2008
|Association between administration of systemic corticosteroids and mortality among critically ill patients with COVID-19: a meta-analysis|
JAC Sterne, S Murthy, JV Diaz, AS Slutsky, J Villar, DC Angus, D Annane, ...
Jama 324 (13), 1330-1341, 2020
|Assessing risk of bias in a randomized trial|
JPT Higgins, J Savović, MJ Page, RG Elbers, JAC Sterne
Cochrane handbook for systematic reviews of interventions, 205-228, 2019
|Oral anticoagulants for prevention of stroke in atrial fibrillation: systematic review, network meta-analysis, and cost effectiveness analysis|
JA López-López, JAC Sterne, HHZ Thom, JPT Higgins, AD Hingorani, ...
bmj 359, 2017
|Evaluation of the Cochrane Collaboration’s tool for assessing the risk of bias in randomized trials: focus groups, online survey, proposed recommendations and their implementation|
J Savović, L Weeks, JAC Sterne, L Turner, DG Altman, D Moher, ...
Systematic reviews 3 (1), 1-12, 2014
|Associations of circulating and dietary vitamin D with prostate cancer risk: a systematic review and dose–response meta-analysis|
R Gilbert, RM Martin, R Beynon, R Harris, J Savovic, L Zuccolo, ...
Cancer Causes & Control 22 (3), 319-340, 2011
|Selenium and prostate cancer: systematic review and meta-analysis|
R Hurst, L Hooper, T Norat, R Lau, D Aune, DC Greenwood, R Vieira, ...
The American journal of clinical nutrition 96 (1), 111-122, 2012
|Association between risk-of-bias assessments and results of randomized trials in Cochrane reviews: the ROBES meta-epidemiologic study|
J Savović, RM Turner, D Mawdsley, HE Jones, R Beynon, JPT Higgins, ...
American Journal of Epidemiology 187 (5), 1113-1122, 2018
|Empirical evidence of study design biases in randomized trials: systematic review of meta-epidemiological studies|
MJ Page, JPT Higgins, G Clayton, JAC Sterne, A Hróbjartsson, J Savović
PloS one 11 (7), e0159267, 2016
|Evaluation of the Cochrane tool for assessing risk of bias in randomized clinical trials: overview of published comments and analysis of user practice in Cochrane and non …|
L Jørgensen, AS Paludan-Müller, DRT Laursen, J Savović, I Boutron, ...
Systematic reviews 5 (1), 1-13, 2016
|Oral anticoagulants for primary prevention, treatment and secondary prevention of venous thromboembolic disease, and for prevention of stroke in atrial fibrillation: systematic …|
JAC Sterne, PN Bodalia, PA Bryden, PA Davies, JA López-López, ...
Health Technology Assessment Volume 21 (9), 2017
|Low alcohol consumption and pregnancy and childhood outcomes: time to change guidelines indicating apparently ‘safe’levels of alcohol during pregnancy? A systematic review and …|
L Mamluk, HB Edwards, J Savović, V Leach, T Jones, THM Moore, S Ijaz, ...
BMJ open 7 (7), 2017
|Height and prostate cancer risk: a large nested case-control study (ProtecT) and meta-analysis|
L Zuccolo, R Harris, D Gunnell, S Oliver, JA Lane, M Davis, J Donovan, ...
Cancer Epidemiology and Prevention Biomarkers 17 (9), 2325-2336, 2008
|Revised Cochrane risk-of-bias tool for randomized trials (RoB 2)|
JPT Higgins, J Savović, MJ Page, JAC Sterne
Bristol: University of Bristol, 2016